Utility of greater wax moth larva (galleria mellonella) for evaluating the toxicity and efficacy of new antimicrobial agents

Advances in Applied Microbiology

Volumn 78, Issue , 2012, Pages 25-53

  Desbois, Andrew P ^a   Coote, Peter J ^a  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

Antimicrobial agents; Minimum inhibitory concentration; Virulence; Wax moth larva

Indexed keywords

1,10 PHENANTHROLINE; ALVESPIMYCIN; AMPHOTERICIN B; ANTIINFECTIVE AGENT; ASTEMIZOLE; AZITHROMYCIN; BAICALIN HYDRATE; CASPOFUNGIN; CINNAMALDEHYDE; CIPROFLOXACIN; COLISTIN; DAPTOMYCIN; FLUCONAZOLE; FLUCYTOSINE; GELDANAMYCIN; GENTAMICIN; HAMAMELITANNIN; LEVOFLOXACIN; MEROPENEM; PENICILLIN G; SERTRALINE; SILVER NITRATE; STREPTOMYCIN; TANESPIMYCIN; TEICOPLANIN; TOBRAMYCIN; UNCLASSIFIED DRUG; VANCOMYCIN; ZINC ION; VIRULENCE FACTOR;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTHROPOD LARVA; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BACTERIAL VIRULENCE; BURKHOLDERIA; BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA INFECTION; BURKHOLDERIA MULTIVORANS; CANDIDA ALBICANS; CANDIDIASIS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DRUG EFFICACY; DRUG SCREENING; FRANCISELLA TULARENSIS; FUNGAL VIRULENCE; GALLERIA MELLONELLA; MOTH; NONHUMAN; SINGLE DRUG DOSE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TULAREMIA; ANIMAL; HUMAN; LARVA; VIRULENCE;

ANIMALIA; GALLERIA MELLONELLA; HEXAPODA; INVERTEBRATA; LEPIDOPTERA; MAMMALIA;

ANIMALS; ANTI-INFECTIVE AGENTS; HUMANS; LARVA; MOTHS; VIRULENCE; VIRULENCE FACTORS;

EID: 84856455527     PISSN: 00652164     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-394805-2.00002-6     Document Type: Chapter

References (83)

1. Abranches J., Miller J.H., Martinez A.R., Simpson-Haidaris P.J., Burne R.A., Lemos J.A. The collagen-binding protein Cnm is required for Streptococcus mutans adherence to and intracellular invasion of human coronary artery endothelial cells. Infect. Immun. 2011, 79:2277-2284.
2. Achterman R.R., Smith A.R., Oliver B.G., White T.C. Sequenced dermatophyte strains: Growth rate, conidiation, drug susceptibilities, and virulence in an invertebrate model. Fungal Genet. Biol. 2011, 48:335-341.
3. Ahmad S., Hunter L., Qin A., Mann B.J., van Hoek M.L. Azithromycin effectiveness against intracellular infections of Francisella. BMC Microbiol. 2010, 10:123.
4. Altincicek B., Linder M., Linder D., Preissner K.T., Vilcinskas A. Microbial metalloproteinases mediate sensing of invading pathogens and activate innate immune responses in the Lepidopteran model host Galleria mellonella. Infect. Immun. 2007, 75:175-183.
5. Anastassopoulou C.G., Fuchs B.B., Mylonakis E. Caenorhabditis elegans-based model systems for antifungal drug discovery. Curr. Pharm. Des. 2011, 17:1225-1233.
6. Aperis G., Fuchs B.B., Anderson C.A., Warner J.E., Calderwood S.B., Mylonakis E. Galleria mellonella as a model host to study infection by the Francisella tularensis live vaccine strain. Microbes Infect. 2007, 9:729-734.
7. Arnesen L.S., Granum P.E., Buisson C., Bohlin J., Nielsen-LeRoux C. Using an insect model to assess correlation between temperature and virulence in Bacillus weihenstephanensis and Bacillus cereus. FEMS Microbiol. Lett. 2011, 317:196-202.
8. Bergin D., Brennan M., Kavanagh K. Fluctuations in haemocyte density and microbial load may be used as indicators of fungal pathogenicity in larvae of Galleria mellonella. Microbes Infect. 2003, 5:1389-1395.
9. Bergin D., Reeves E.P., Renwick J., Wientjes F.B., Kavanagh K. Superoxide production in Galleria mellonella hemocytes: Identification of proteins homologous to the NADPH oxidase complex of human neutrophils. Infect. Immun. 2005, 73:4161-4170.
10. Bergin D., Murphy L., Keenan J., Clynes M., Kavanagh K. Pre-exposure to yeast protects larvae of Galleria mellonella from a subsequent lethal infection by Candida albicans and is mediated by the increased expression of antimicrobial peptides. Microbes Infect. 2006, 8:2105-2112.
11. Brackman G., Cos P., Maes L., Nelis H.J., Coenye T. Quorum sensing inhibitors increase the susceptibility of bacterial biofilms to antibiotics in vitro and in vivo. Antimicrob. Agents Chemother. 2011, 55:2655-2661.
12. Breger J., Fuchs B.B., Aperis G., Moy T.I., Ausubel F.M., Mylonakis E. Antifungal chemical compounds identified using a C. elegans pathogenicity assay. PLoS Pathog. 2007, 3:168-178.
13. Brennan M., Thomas D.Y., Whiteway M., Kavanagh K. Correlation between virulence of Candida albicans mutants in mice and Galleria mellonella larvae. FEMS Immunol. Med. Microbiol. 2002, 34:153-157.
14. Brown S.E., Howard A., Kasprzak A.B., Gordon K.H., East P.D. A peptidomics study reveals the impressive antimicrobial arsenal of the wax moth Galleria mellonella. Insect Biochem. Mol. Biol. 2009, 39:792-800.
15. Cerenius L., Lee B.L., Söderhäll K. The proPO-system: Pros and cons for its role in invertebrate immunity. Trends Immunol. 2008, 29:263-271.
16. Chamilos G., Lionakis M.S., Lewis R.E., Kontojiannis D.P. Role of mini-host models in the study of medically important fungi. Lancet Infect. Dis. 2007, 7:42-55.
17. Champion O.L., Cooper I.A., James S.L., Ford D., Karlyshev A., Wren B.W., Duffield M., Oyston P.C., Titball R.W. Galleria mellonella as an alternative infection model for Yersinia pseudotuberculosis. Microbiology 2009, 155:1516-1522.
18. Chen Y.-L., Btrand A., Morrison E.L., Silao F.G.S., Bigol U.G., Malbas F.F., Nett J.E., Andes D.R., Solis N.V., Filler S.G., Averette A., Heitman J. Calcineurin controls drug tolerance, hyphal growth, and virulence in Candida dubliniensis. Eukaryot. Cell 2011, 10:803-819.
19. Costello A., Herbert G., Fabunmi L., Schaffer K., Kavanagh K.A., Caraher E.M., Callaghan M., McClean S. Virulence of an emerging respiratory pathogen, genus Pandoraea, in vivo and its interactions with lung epithelial cells. J. Med. Microbiol. 2011, 60:289-299.
20. Cotter G., Doyle S., Kavanagh K. Development of an insect model for the in vivo pathogenicity testing of yeasts. FEMS Immunol. Med. Microbiol. 2000, 27:163-169.
21. Coughlan A., Scanlon K., Mahon B.P., Towler M.R. Zinc and silver glass polyalkenoate cements: An evaluation of their antibacterial nature. Biomed. Mater. Eng. 2010, 20:99-106.
22. Cowen L.E., Singh S.D., Köhler J.R., Collins C., Zaas A.K., Schell W.A., Aziz H., Mylonakis E., Perfect J.R., Whitesell L., Lindquist S. Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease. Proc. Natl. Acad. Sci. USA 2009, 106:2818-2823.
23. Cytryńska M., Mak P., Zdybicka-Barabas A., Suder P., Jakubowicz T. Purification and characterization of eight peptides from Galleria mellonella immune hemolymph. Peptides 2006, 28:533-546.
24. d'Enfert C., Vecchiarelli A., Brown A.J.P. Bioluminescent fungi for real-time monitoring of fungal infections. Virulence 2010, 1:174-176.
25. Desalermos A., Muhammed M., Glavis-Bloom J., Mylonakis E. Using Caenorhabditis elegans for antimicrobial drug discovery. Expert Opin. Drug Discov. 2011, 6:645-652.
26. Desbois A.P., Coote P.J. Wax moth larva (Galleria mellonella): An in vivo model for assessing the efficacy of antistaphylococcal agents. J. Antimicrob. Chemother. 2011, 66:1785-1790.
27. Fedhila S., Buisson C., Dussurget O., Serror P., Glomski I.J., Liehl P., Lereclus D., Nielsen-LeRoux C. Comparative analysis of the virulence of invertebrate and mammalian pathogenic bacteria in the oral infection model Galleria mellonella. J. Invertebr. Pathol. 2010, 103:24-29.
28. Fuchs B.B., Mylonakis E. Using non-mammalian hosts to study fungal virulence and host defense. Curr. Opin. Microbiol. 2006, 9:346-351.
29. Fuchs B.B., O'Brien E., El Khoury J.B., Mylonakis E. Methods for using Galleria mellonella as a model host to study fungal pathogenesis. Virulence 2010, 1:475-482.
30. Fuchs B.B., Eby J., Nobile C.J., El Khoury J.B., Mitchell A.P., Mylonakis E. Role of filamentation in Galleria mellonella killing by Candida albicans. Microbes Infect. 2010, 12:488-496.
31. Fuchs B.B., Bishop L.R., Kovacs J.A., Mylonakis E. Galleria mellonella are resistant to Pneumocystis murina infection. Mycopathologia 2011, 171:273-277.
32. Gao W., Chua K., Davies J.K., Newton H.J., Seemann T., Harrison P.F., Holmes N.E., Rhee H.-W., Hong J.-I., Hartland E.L., Stinear T.P., Howden B.P. Two novel point mutations in clinical Staphylococcus aureus reduce linezolid susceptibility and switch on the stringent response to promote persistent infection. PLoS Pathog. 2010, 6:e1000944.
33. García-Lara J., Needham A.J., Foster S.J. Invertebrates as animal models for Staphylococcus aureus pathogenesis: A window into host-pathogen interaction. FEMS Immunol. Med. Microbiol. 2005, 43:311-323.
34. García-Rodas R., Casadevall A., Rodríguez-Tudela J.L., Cuenca-Estrella M., Zaragoza O. Cryptococcus neoformans capsular enlargement and cellular gigantism during Galleria mellonella infection. PLoS One 2011, 6:e24485.
35. Hornsey M., Wareham D.W. In vivo efficacy of glycopeptides-colistin combination therapies in a Galleria mellonella model of Acinetobacter baumannii infection. Antimicrob. Agents Chemother. 2011, 55:3534-3537.
36. Hutchens M., Luker G.D. Applications of bioluminescence imaging to the study of infectious diseases. Cell. Microbiol. 2007, 9:2315-2322.
37. Jander G., Rahme L.G., Ausubel F.M. Positive correlation between virulence of Pseudomonas aeruginosa mutants in mice and insects. J. Bacteriol. 2000, 182:3843-3845.
38. Jiravanichpaisal P., Söderhäll K., Söderhäll I. Inflammation in arthropods. Curr. Pharm. Des. 2010, 16:4166-4174.
39. Kaito C., Akimitsu N., Watanabe H., Sekimizu K. Silkworm larvae as an animal model of bacterial infection pathogenic to humans. Microb. Pathog. 2002, 32:183-190.
40. Kavanagh K., Reeves E.P. Exploiting the potential of insects for in vivo pathogenicity testing of microbial pathogens. FEMS Microbiol. Rev. 2004, 28:101-112.
41. Kelly J., Kavanagh K. Caspofungin primes the immune response of the larvae of Galleria mellonella and induces a non-specific antimicrobial response. J. Med. Microbiol. 2011, 60:189-196.
42. Konkel M.E., Tilly K. Temperature-regulated expression of bacterial virulence genes. Microbes Infect. 2000, 2:157-166.
43. Laws T.R., Smith S.A., Smith M.P., Harding S.V., Atkins T.P., Titball R.W. The nematode Panagrellus redivivus is susceptible to killing by human pathogens at 37°C. FEMS Microbiol. Lett. 2005, 250:77-83.
44. Miyata S., Casey M., Frank D.W., Ausubel F.M., Drenkard E. Use of the Galleria mellonella caterpillar as a model host to study the role of type III secretion system in Pseudomonas aeruginosa pathogenesis. Infect. Immun. 2003, 71:2404-2413.
45. Mowlds P., Kavanagh K. Effect of pre-incubation temperature on susceptibility of Galleria mellonella larvae to infection by Candida albicans. Mycopathologia 2008, 165:5-12.
46. Mowlds P., Barron A., Kavanagh K. Physical stress primes the immune response of Galleria mellonella larvae to infection by Candida albicans. Microbes Infect. 2008, 10:628-634.
47. Moy T.I., Ball A.R., Anklesaria Z., Casadei G., Lewis K., Ausubel F.M. Identification of novel antimicrobials using a live-animal infection model. Proc. Natl. Acad. Sci. USA 2006, 103:10414-10419.
48. Muhammed M., Coleman J.J., Kourkoumpetis T.K., Mylonakis E. Invertebrate animal models as tools to study fungal pathogenesis and treatment. Int. J. Clin. Rev. 2011, 4:127-132.
49. Mukherjee K., Altincicek B., Hain T., Domann E., Vilcinskas A., Chakraborty T. Galleria mellonella as a model system for studying Listeria pathogenesis. Appl. Environ. Microbiol. 2010, 76:310-317.
50. Mukherjee K., Domann E., Hain T. The greater wax moth Galleria mellonella as an alternative model host for human pathogens. Insect Biotechnology, Biologically-inspired Systems 2010, Vol. 2:3-14. A. Vilcinskas (Ed.).
51. Mukherjee K., Abu Mraheil M., Silva S., Müller D., Cemic F., Hemberger J., Hain T., Vilcinskas A., Chakraborty T. Anti-Listeria activities of Galleria mellonella hemolymph proteins. Appl. Environ. Microbiol. 2011, 77:4237-4240.
52. Mylonakis E. Galleria mellonella and the study of fungal pathogenesis: Making the case for another genetically tractable model host. Mycopathologia 2008, 165:1-3.
53. Mylonakis E., Moreno R., El Khoury J.B., Idnurm A., Heitman J., Calderwood S.B., Ausubel F.M., Diener A. Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis. Infect. Immun. 2005, 73:3842-3850.
54. Mylonakis E., Casadevall A., Ausubel F.M. Exploiting amoeboid and non-vertebrate animal model systems to study the virulence of human pathogenic fungi. PLoS Pathog. 2007, 3:859-865.
55. Nicoletti M., Iacobino A., Prosseda G., Fiscarelli E., Zarrilli R., De Carolis E., Petrucca A., Nencioni L., Colonna B., Casalino M. Stenotrophomonas maltophila strains from cystic fibrosis patients: Genomic variability and molecular characterization of some virulence determinants. Int. J. Med. Microbiol. 2011, 301:34-43.
56. Olsen R.J., Watkins M.E., Cantu C.C., Beres S.B., Musser J.M. Virulence of serotype M3 Group A Streptococcus strains in wax worms (Galleria mellonella larvae). Virulence 2011, 2:111-119.
57. Paul S.M., Mytelka D.S., Dunwiddie C.T., Persinger C.C., Munos B.H., Lindborg S.R., Schacht A.L. How to improve R&D productivity: The pharmaceutical industry's grand challenge. Nat. Rev. Drug. Discov. 2010, 9:203-214.
58. Peleg A.Y., Jara S., Monga D., Eliopoulos G.M., Moellering R.C., Mylonakis E. Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics. Antimicrob. Agents Chemother. 2009, 53:2605-2609.
59. Peleg A.Y., Monga D., Pillai S., Mylonakis E., Moellering R.C., Eliopoulos G.M. Reduced susceptibility to vancomycin influences pathogenicity in Staphylococcus aureus infection. J. Infect. Dis. 2009, 199:532-536.
60. Ratcliffe N.A., Brookman J.L., Rowley A.F. Activation of the prophenoloxidase cascade and initiation of nodule formation in locusts by bacterial lipopolysaccharides. Dev. Comp. Immunol. 1991, 15:33-39.
61. Rowan R., Moran C., McCann M., Kavanagh K. Use of Galleria mellonella larvae to evaluate the in vivo anti-fungal activity of [Ag2(mal)(phen)3]. Biometals 2009, 22:461-467.
62. Salamitou S., Ramisse F., Brehélin M., Bourguet D., Gilois N., Gominet M., Hernandez E., Lereclus D. The plcR regulon is involved in the opportunistic properties of Bacillus thuringiensis and Bacillus cereus in mice and insects. Microbiology 2000, 146:2825-2832.
63. Schell M.A., Lipscomb L., DeShazer D. Comparative genomics and an insect model rapidly identify novel virulence genes of Burkholderia mallei. J. Bacteriol. 2008, 190:2306-2313.
64. Scully L.R., Bidochkam M.J. Serial passage of the opportunistic pathogen Aspergillus flavus through an insect host yields decreased saprobic capacity. Can. J. Microbiol. 2005, 51:185-189.
65. Seabra R., Bhogal N. Hospital infections, animal models and alternatives. Eur. J. Clin. Microbiol. Infect. Dis. 2009, 28:561-568.
66. Seed K.D., Dennis J.J. Development of Galleria mellonella as an alternative infection model for the Burkholderia cepacia complex. Infect. Immun. 2008, 76:1267-1275.
67. Seed K.D., Dennis J.J. Experimental bacteriophage therapy increases survival of Galleria mellonella larvae infected with clinically relevant strains of the Burkholderia cepacia complex. Antimicrob. Agents Chemother. 2009, 53:2205-2208.
68. Senior N.J., Bagnall M.C., Champion O.L., Reynolds S.E., La Ragione R.M., Woodward M.J., Salguero F.J., Titball R.W. Galleria mellonella as an infection model for Campylobacter jejuni virulence. J. Med. Microbiol. 2011, 60:661-669.
69. Silver A.C., Williams D., Faucher J., Horneman A.J., Gogarten J.P., Graf J. Complex evolutionary history of the Aeromonas veronii group revealed by host interaction and DNA sequence data. PLoS One 2011, 6:e16751.
70. Slater J.L., Gregson L., Denning D.W., Warn P.A. Pathogenicity of Aspergillus fumigatus mutants assessed in Galleria mellonella matches that in mice. Med. Mycol. 2011, 49:S107-S113.
71. Smoot L.M., Smoot J.C., Graham M.R., Somerville G.A., Sturdevant D.E., Lux Migliaccio C.A., Sylva G.L., Musser J.M. Global differential gene expression in response to growth temperature alteration in group A Streptococcus. Proc. Natl. Acad. Sci. USA 2001, 98:10416-10421.
72. Söderhäll K., Smith V.J. Prophenoloxidase-activating cascade as a recognition and defense system in arthropods. Hemocytic and Humoral Immunity in Arthropods 1986, 251-285. Wiley-Interscience, New York. A.P. Gupta (Ed.).
73. Spitzer M., Griffiths E., Blakely K.M., Wildenhain J., Ejim L., Rossi L., De Pascale G., Curak J., Brown E., Tyers M., Wright G.D. Cross-species discovery of syncretic drug combinations that potentiate the antifungal fluconazole. Mol. Syst. Biol. 2011, 7:499.
74. Vilcinskas A. Lepidopterans as model mini-hosts for human pathogens and as a resource for peptide antibiotics. Molecular Biology and Genetics of the Lepidoptera 2010, 293-305. CRC Press, Boca Raton. M.R. Goldsmith, F. Marec (Eds.).
75. Vilcinskas A. Anti-infective therapeutics from the Lepidopteran model host Galleria mellonella. Curr. Pharm. Des. 2011, 17:1240-1245.
76. Vogel H., Altincicek B., Glöckner G., Vilcinskas A. A comprehensive transcriptome and immune-gene repertoire of the lepidopteran model host Galleria mellonella. BMC Genomics 2011, 12:308.
77. Vu K., Gelli A. Astemizole and an analogue promote fungicidal activity of fluconazole against Crptococcus neoformans var. grubii and Cryptococcus gattii. Med. Mycol. 2010, 48:255-262.
78. Walters J.B., Ratcliffe N.A. Studies on the in vivo cellular reactions of insects: Fate of pathogenic and non-pathogenic bacteria in Galleria mellonella nodules. J. Insect Physiol. 1983, 29:417-424.
79. Wand M.E., Müller C.M., Titball R.W., Michell S.L. Macrophage and Galleria mellonella infection models reflect the virulence of naturally occurring isolates of B. pseudomallei, B. thailandensis and B. oklahomensis. BMC Microbiol. 2011, 11:11.
80. World Health Organization Policy Package to Combat Antimicrobial Resistance 2011, [5 October 2011]. http://www.who.int/world-health-day/2011/policybriefs/en/index.html.
81. Zak O., Tosch W., Sande M.A. Correlation of antibacterial activities of antibiotics in vitro and in animal models of infection. J. Antimicrob. Chemother 1985, 15:A273-282.
82. Zak O., O'Reilly T. Animal models in the evaluation of antimicrobial agents Antimicrob. Agents Chemother 1991, 35:1527-1531.
83. Zak O., O'Reilly T. Animal infection models and ethics-The perfect infection model. J. Antimicrob. Chemother. 1993, 31:D193-D205.